CONCORD BIOTECH
|
The Current P/S Ratio of CONCORD BIOTECH is 11.03.
| Share Price | ₹1,221.6 | Feb 27,2026 |
| Market Cap | ₹12,777.4 Cr | |
| Sales-TTM | ₹1,158.7 Cr | TTM-Consolidated Results |
| Price/Sales | 11.03x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CONCORD BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹12,777.4 Cr] as on Feb 27,2026
(/) Sales [ ₹1,158.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 11.03x ]
Thus, for CONCORD BIOTECH , the investors are currently willing to pay '11.03 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD BIOTECH !
The chart below summarizes the trend in P/S Ratio of CONCORD BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of CONCORD BIOTECH
PS Ratio Performance Analysis for CONCORD BIOTECH
- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.05x.
- CONCORD BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 15.66x.
- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does CONCORD BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CONCORD BIOTECH | 1,158.7 | 11.03 | 12,777.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.34 | 417,028.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.51 | 170,237.0 |
| CIPLA LTD | 28,351.1 | 3.84 | 108,861.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.52 | 146,801.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.10 | 107,435.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.67 | 92,784.1 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.56 | 92,825.1 |
| LUPIN LTD | 26,150.5 | 4.02 | 105,182.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.14 | 70,947.8 |
| ABBOTT INDIA LTD | 6,824.1 | 8.25 | 56,300.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.14x |
| Max industry PS | 16.51x |
| Median industry PS | 6.67x |
| Average industry PS | 7.09x |
You may also like the below Video Courses